Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
497 | 22707 | 49.2 | 81% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
497 | 3 | CANNABINOID//ANANDAMIDE//ENDOCANNABINOIDS | 22707 |
535 | 2 | CANNABINOID//ENDOCANNABINOIDS//ANANDAMIDE | 14838 |
1435 | 2 | TRPV1//TRPA1//CAPSAICIN | 7869 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CANNABINOID | authKW | 2745447 | 12% | 76% | 2678 |
2 | ANANDAMIDE | authKW | 1446226 | 5% | 88% | 1225 |
3 | ENDOCANNABINOIDS | authKW | 1422379 | 6% | 78% | 1354 |
4 | CANNABINOID RECEPTORS | authKW | 977703 | 4% | 83% | 877 |
5 | CB1 RECEPTOR | authKW | 601372 | 2% | 82% | 545 |
6 | CANNABIS | authKW | 560562 | 5% | 38% | 1089 |
7 | MARIJUANA | authKW | 491955 | 4% | 45% | 811 |
8 | ENDOCANNABINOID GRP | address | 486952 | 2% | 87% | 419 |
9 | 2 ARACHIDONOYLGLYCEROL | authKW | 443168 | 2% | 91% | 362 |
10 | TRPV1 | authKW | 434749 | 3% | 56% | 575 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 57130 | 30% | 1% | 6897 |
2 | Pharmacology & Pharmacy | 41926 | 27% | 1% | 6030 |
3 | Substance Abuse | 14788 | 4% | 1% | 900 |
4 | Psychiatry | 6796 | 7% | 0% | 1652 |
5 | Chemistry, Medicinal | 6670 | 6% | 1% | 1317 |
6 | Physiology | 4394 | 6% | 0% | 1309 |
7 | Biochemistry & Molecular Biology | 3979 | 15% | 0% | 3484 |
8 | Behavioral Sciences | 3000 | 3% | 0% | 692 |
9 | Cell Biology | 2307 | 7% | 0% | 1642 |
10 | Clinical Neurology | 1732 | 5% | 0% | 1227 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ENDOCANNABINOID GRP | 486952 | 2% | 87% | 419 |
2 | GILL BIOMOL SCI | 63185 | 0% | 74% | 64 |
3 | ION CHANNEL | 62559 | 0% | 53% | 88 |
4 | EUROPEAN BRAIN CERC | 48187 | 0% | 58% | 62 |
5 | BIOMOL CHEM | 48136 | 1% | 13% | 282 |
6 | PHYSIOL STUDIES | 45678 | 0% | 34% | 101 |
7 | UNITE CHIM PHARMACEUT RADIOPHARM | 44174 | 0% | 65% | 51 |
8 | PHARMACOL CLIN NEUROSCI | 31531 | 0% | 22% | 107 |
9 | OYO INVEST | 28780 | 0% | 79% | 27 |
10 | IST CHIM MOL INTE SE BIOL | 28031 | 0% | 32% | 66 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BRITISH JOURNAL OF PHARMACOLOGY | 26928 | 3% | 3% | 606 |
2 | MOLECULAR PAIN | 15787 | 0% | 12% | 101 |
3 | NEUROPHARMACOLOGY | 13984 | 1% | 3% | 318 |
4 | EUROPEAN JOURNAL OF PHARMACOLOGY | 12638 | 2% | 2% | 531 |
5 | PSYCHOPHARMACOLOGY | 10437 | 1% | 3% | 314 |
6 | BEHAVIOURAL PHARMACOLOGY | 9111 | 1% | 6% | 116 |
7 | PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR | 8670 | 1% | 2% | 291 |
8 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 8391 | 2% | 2% | 376 |
9 | DRUG AND ALCOHOL DEPENDENCE | 7982 | 1% | 3% | 193 |
10 | CHANNELS | 7668 | 0% | 11% | 55 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CANNABINOID | 2745447 | 12% | 76% | 2678 | Search CANNABINOID | Search CANNABINOID |
2 | ANANDAMIDE | 1446226 | 5% | 88% | 1225 | Search ANANDAMIDE | Search ANANDAMIDE |
3 | ENDOCANNABINOIDS | 1422379 | 6% | 78% | 1354 | Search ENDOCANNABINOIDS | Search ENDOCANNABINOIDS |
4 | CANNABINOID RECEPTORS | 977703 | 4% | 83% | 877 | Search CANNABINOID+RECEPTORS | Search CANNABINOID+RECEPTORS |
5 | CB1 RECEPTOR | 601372 | 2% | 82% | 545 | Search CB1+RECEPTOR | Search CB1+RECEPTOR |
6 | CANNABIS | 560562 | 5% | 38% | 1089 | Search CANNABIS | Search CANNABIS |
7 | MARIJUANA | 491955 | 4% | 45% | 811 | Search MARIJUANA | Search MARIJUANA |
8 | 2 ARACHIDONOYLGLYCEROL | 443168 | 2% | 91% | 362 | Search 2+ARACHIDONOYLGLYCEROL | Search 2+ARACHIDONOYLGLYCEROL |
9 | TRPV1 | 434749 | 3% | 56% | 575 | Search TRPV1 | Search TRPV1 |
10 | CANNABIDIOL | 411117 | 2% | 83% | 370 | Search CANNABIDIOL | Search CANNABIDIOL |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PACHER, P , BATKAI, S , KUNOS, G , (2006) THE ENDOCANNABINOID SYSTEM AS AN EMERGING TARGET OF PHARMACOTHERAPY.PHARMACOLOGICAL REVIEWS. VOL. 58. ISSUE 3. P. 389-462 | 951 | 85% | 790 |
2 | LIGRESTI, A , DE PETROCELLIS, L , DI MARZO, V , (2016) FROM PHYTOCANNABINOIDS TO CANNABINOID RECEPTORS AND ENDOCANNABINOIDS: PLEIOTROPIC PHYSIOLOGICAL AND PATHOLOGICAL ROLES THROUGH COMPLEX PHARMACOLOGY.PHYSIOLOGICAL REVIEWS. VOL. 96. ISSUE 4. P. 1593 -1659 | 807 | 90% | 1 |
3 | HOWLETT, AC , BARTH, F , BONNER, TI , CABRAL, G , CASELLAS, P , DEVANE, WA , FELDER, CC , HERKENHAM, M , MACKIE, K , MARTIN, BR , ET AL (2002) INTERNATIONAL UNION OF PHARMACOLOGY. XXVII. CLASSIFICATION OF CANNABINOID RECEPTORS.PHARMACOLOGICAL REVIEWS. VOL. 54. ISSUE 2. P. 161 -202 | 375 | 95% | 1398 |
4 | HASHIMOTODANI, Y , UCHIGASHIMA, M , WATANABE, M , KANO, M , OHNO-SHOSAKU, T , (2009) ENDOCANNABINOID-MEDIATED CONTROL OF SYNAPTIC TRANSMISSION.PHYSIOLOGICAL REVIEWS. VOL. 89. ISSUE 1. P. 309 -380 | 427 | 75% | 502 |
5 | NILIUS, B , SZALLASI, A , (2014) TRANSIENT RECEPTOR POTENTIAL CHANNELS AS DRUG TARGETS: FROM THE SCIENCE OF BASIC RESEARCH TO THE ART OF MEDICINE.PHARMACOLOGICAL REVIEWS. VOL. 66. ISSUE 3. P. 676 -814 | 741 | 47% | 64 |
6 | IANNOTTI, FA , DI MARZO, V , PETROSINO, S , (2016) ENDOCANNABINOIDS AND ENDOCANNABINOID-RELATED MEDIATORS: TARGETS, METABOLISM AND ROLE IN NEUROLOGICAL DISORDERS.PROGRESS IN LIPID RESEARCH. VOL. 62. ISSUE . P. 107 -128 | 312 | 87% | 6 |
7 | LAMBERT, DM , FOWLER, CJ , (2005) THE ENDOCANNABINOID SYSTEM: DRUG TARGETS, LEAD COMPOUNDS, AND POTENTIAL THERAPEUTIC APPLICATIONS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 48. ISSUE 16. P. 5059-5087 | 381 | 97% | 222 |
8 | BARON, EP , (2015) COMPREHENSIVE REVIEW OF MEDICINAL MARIJUANA, CANNABINOIDS, AND THERAPEUTIC IMPLICATIONS IN MEDICINE AND HEADACHE: WHAT A LONG STRANGE TRIP IT'S BEEN ....HEADACHE. VOL. 55. ISSUE 6. P. 885 -916 | 396 | 74% | 8 |
9 | FREUND, TF , KATONA, I , PIOMELLI, D , (2003) ROLE OF ENDOGENOUS CANNABINOIDS IN SYNAPTIC SIGNALING.PHYSIOLOGICAL REVIEWS. VOL. 83. ISSUE 3. P. 1017-1066 | 288 | 80% | 839 |
10 | PERTWEE, RG , HOWLETT, AC , ABOOD, ME , ALEXANDER, SPH , DI MARZO, V , ELPHICK, MR , GREASLEY, PJ , HANSEN, HS , KUNOS, G , MACKIE, K , ET AL (2010) INTERNATIONAL UNION OF BASIC AND CLINICAL PHARMACOLOGY. LXXIX. CANNABINOID RECEPTORS AND THEIR LIGANDS: BEYOND CB1 AND CB2.PHARMACOLOGICAL REVIEWS. VOL. 62. ISSUE 4. P. 588 -631 | 250 | 71% | 515 |
Classes with closest relation at Level 3 |